Allan Joseph, MD
Obstetrics & Gynecology · Augusta, GANPI 1407825094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,331 and has fallen 57.3% since, to $569 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $22.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$566
- Astellas Pharma US Inc$514
- Daiichi Sankyo Inc.$408
- Exeltis, USA Inc.$304
- Gynesonics, Inc.$267
- plus $3K from 37 others
Across 35 payments — averaging $4435.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$124K
- Abbott$28K
- Myovant Sciences Inc.$3K
What the payments were for
- Food & beverage$5,61696%
- Education$2484%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $1,076 |
| Novo Nordisk | 24 | $566 |
| Astellas Pharma US Inc | 23 | $514 |
| Daiichi Sankyo Inc. | 11 | $408 |
| Exeltis, USA Inc. | 19 | $304 |
| Gynesonics, Inc. | 1 | $267 |
| Pfizer | 17 | $264 |
| Hologic Sales And Service, LLC | 10 | $248 |
| Sumitomo Pharma America, Inc. | 9 | $246 |
| Mayne Pharma Commercial LLC | 12 | $207 |
| Channel Medsystems, Inc. | 4 | $161 |
| Millicent US Inc | 7 | $158 |
| Therapeuticsmd, Inc. | 8 | $137 |
| Biogen | 5 | $123 |
| Mimedx Group, Inc. | 1 | $119 |
| Amniox Medical, Inc. | 1 | $107 |
| Myovant Sciences Inc. | 6 | $96 |
| Dysis Medical, Inc. | 2 | $76 |
| Organon | 4 | $67 |
| Caldera Medical, Inc | 2 | $66 |
| Agile Therapeutics, Inc. | 4 | $64 |
| Bayer | 3 | $60 |
| Lupin Inc. | 3 | $59 |
| Amgen | 3 | $48 |
| Merck | 3 | $42 |
| AMAG Pharmaceuticals, Inc. | 3 | $40 |
| Davol Inc. | 1 | $37 |
| Johnson & Johnson | 2 | $33 |
| Monaghan Medical Corporation | 1 | $32 |
| Evofem Biosciences, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $25 |
| Northgate Technologies, Inc. | 1 | $23 |
| Axonics, Inc. | 1 | $23 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Coloplast | 1 | $17 |
| Medtronic | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Avanos Medical | 1 | $14 |
| Coopersurgical, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Intuitive Surgical | 1 | $12 |
| Avion Pharmaceuticals | 1 | $12 |
| Aspira Women's Health Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$267
- INJECTAFER$250
- Saxenda$125
- Veozah$124
- MYFEMBREE$120
- NEOX$107
- CLARIX$107
- Myosure$101
How this compares
$5,864 in reported general payments places this provider in the 90th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 20 | $17,990 |
| Estradiol | 290 | $8,374 |
| ProgesteroneProgesterone, Micronized | 183 | $6,687 |
| Liothyronine Sodium | 157 | $6,552 |
| PremarinEstrogens, Conjugated | 11 | $4,885 |
| Estradiol (Twice Weekly)Estradiol | 70 | $4,422 |
| SynthroidLevothyroxine Sodium | 44 | $3,880 |
| Estradiol Valerate | 12 | $1,263 |
| Armour ThyroidThyroid,pork | 11 | $943 |
| Np ThyroidThyroid,pork | 15 | $818 |
| FyavolvNorethindrone Ac/Eth Estradiol | 13 | $660 |
| Spironolactone | 58 | $649 |
| Levothyroxine Sodium | 67 | $524 |
| ValacyclovirValacyclovir Hcl | 17 | $522 |
| Metronidazole | 22 | $440 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $514 | $17,99020 claims |
| PfizerPremarin | $264 | $4,88511 claims |
| AbbVieSynthroid, Armour Thyroid | $1,076 | $4,82355 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Augusta
- Murray FreedmanAugusta$48K
- Camilla ChanceAugusta$12K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.